Quanterix Corporation is a life sciences company. The Company develops and commercializes ultra-sensitive digital immunoassay platforms that advance life sciences research and diagnostics. Its platforms are based on its proprietary digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, Nova Beads, and neurofilament light chain (NfL) antibodies and NfL ELISA kits. It also offers contract research services for customers and laboratory developed test services through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.